September 26, 2023/Pediatrics/Cardiology

A New Metric for Donor-Recipient Size Matching in Pediatric Heart Transplantation?

Findings from more than 7,500 donor-recipient pairs

22-CHP-3075509-CQD-650×450-Amdani

In the field of heart transplantation, the conventional method for determining donor-recipient (D-R) size matching has been using height and weight assessment. However, total cardiac volume (TCV) may be the optimal tool for predicting graft survival, according to the findings from a recent study published in JACC: Heart Failure. Adopting a standardized approach to size matching across centers could be key to reducing donor heart discard and ultimately allow more children with end-stage heart failure to get transplanted.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pediatric transplant cardiologist Shahnawaz Amdani, MD, first author of the study, says the D-R heart match is a critical consideration every time a center accepts a donor heart for a patient who needs a transplant. “The first thing we look at is how the donor’s heart matches with the recipient’s heart. Until recently, the only way to determine a match was to make an educated guess based on the donor and recipient’s height and weight.”

It’s a decision that needs to be made decisively and, occasionally, at an unexpected hour—like in the middle of the night—making accuracy and simplicity of these metrics essential.

Rethinking a traditional model

The traditional inputs of height and weight have been a reliable metric for D-R matching since the beginning of heart transplantation. These variables are also collected by United Network for Organ Sharing (UNOS). The impetus for rethinking this assumption, explains Dr. Amdani, is twofold: increasing rates of obesity and emerging imaging technology.

The rates of obesity have increased significantly in both general and pediatric populations, calling the presumed accuracy of these metrics into question. For example, a younger child with a similar weight to that of a much older child may appear on paper to be an appropriate match, but the “true heart size discrepancy” could put them at risk for suboptimal posttransplant outcomes.

Unlike adults where predicted heart mass has emerged as a metric accepted by all adult heart transplant cardiologists for D-R matching, to date, there is no such universally accepted metric for pediatric heart transplant candidates.

But could this metric work in children?

Dr. Amdani recalls discourse following a 2019 International Society for Heart and Lung Transplantation pediatric report, for which the theme was D-R size matching. It was suggested that weight may be the best measure for D-R matching in pediatric heart transplant, an assumption that led Dr. Amdani and team on a quest for answers.

Advertisement

Using the Pediatric Heart Transplant Society database, the team analyzed data from 7,715 D-R pairs over the span of nearly two decades (1993-2021). Their primary aim was to determine metrics of size mismatch that could predict graft survival at one and five years posttransplant. Specifically, they examined the effects of size mismatch by height, weight, body mass index, body surface area, predicted heart mass and TCV on graft survival, rejection, and cardiac allograft vasculopathy.1

Height and TCV: independent predictors of graft survival

Because the newer models, PHM and TCV, rely on advanced cardiac imaging data (CT, MRI), and these were not available to the study team, the team instead used validated formulas to calculate D-R predicted heart mass and total cardiac volume.

Notably, their findings revealed a wide discrepancy of D-R mismatch depending on the variable that was used. Only 36% of pairs were well-matched using the weight metric alone, while height and TCV metrics provided a much higher predictive match rate at 71% and 93%, respectively.

A closer look at height and TCV

Other findings about height and estimated TCV metrics in posttransplant graft survival are as follows.

  • The effect of D-R mismatch by height and TCV on graft survival are not linear, though, Dr. Amdani says there is likely a critical point beyond which risk increases exponentially.
  • Under sizing donors by height relative to recipient poses more risk to graft survival than oversizing.
  • When using TCV, decreased graft loss was noted with a minimal degree of mismatch when the donor is slightly undersized relative to the recipient (up to 20%). Also, oversizing donor by up to 25% was not associated with increased graft loss.

These findings raise an important point about looking at TCV more prospectively to understand and refine parameters for accepting a donor heart based on this metric, which holds great potential but is currently underexplored.

Overcoming challenges to adoption

While many experts, like Dr. Amdani, favor use of the TCV metric, its broader adoption within the pediatric heart transplant community will require seamless integration into practice, something he says is still not yet available for practical use.

Advertisement

“To integrate TCV-based matching into clinical practice, we need some sophistication as to how the volumes are calculated and, subsequently, D-R pairs matched. As a clinician, I should be able to input minimal amount of data and have a calculator that accurately demonstrates how matched the donor cardiac volume is relative to the recipient’s cardiac volume,” he says.

But it’s time we rethink our assumptions about traditional height and weight approaches that have been around for 30-plus years and may not be the best ways to match donor-recipient hearts in 2023.”

Reference

  1. Amdani S, Aljohani OA, Kirklin JK, Cantor R, Koehl D, Schumacher K, Nandi D, Khoury M, Dreyer W, Rose-Felker K, Nasman C, Kemna MS. Assessing Donor-Recipient Size Mismatch in Pediatric Heart Transplantation: Lessons Learned From Over 7,500 Transplants. JACC Heart Fail. 2023 Aug 21:S2213-1779(23)00391-8. doi: 10.1016/j.jchf.2023.07.005. Epub ahead of print. PMID: 37676215.

Related Articles

Young patient with endoscopy device
April 17, 2024/Pediatrics/Cardiology
Cleveland Clinic Plays Many Roles in Developing Pediatric-Specific Devices

Programs bring age- and size-appropriate technology to children

CQD-3982358-amdani-650×450
February 13, 2024/Pediatrics/Cardiology
Experts Define Research Gaps in Pediatric Heart Failure

Basic understanding of condition and treatment is lacking

CQD-4408475-C4AI-650×450
January 25, 2024/Pediatrics/Cardiology
AI Center to Advance Care for Congenital Heart Disease

Early projects include predicting cardiac arrest, kidney injury and low cardiac output syndrome after surgery

CQD-4040875-marino-longterm-650×450
January 15, 2024/Pediatrics/Cardiology
Exploring Long-Term Quality of Life in Patients With Congenital Heart Disease

What factors can be modified to improve outcomes?

23-CHP-3814908 CQD Rao – Fetal Echocardiography
December 20, 2023/Pediatrics/Cardiology
Fetal Echo, Team Care Optimize Congenital Heart Disease Outcome

New course highlights role of imaging in the diagnosis and management in TOF

23-CHP-3770312 CQD Anderson – Chemotherapy and Radiation Toxicities
August 16, 2023/Pediatrics/Cardiology
New Consensus Statement Seeks To Clarify Aortic Root Terminology

Malformation classification provides uniform nomenclature for use in patient care and procedure coding

23-CHP-3548760 CQD Boyle Najm – Jude Heart Defect
June 16, 2023/Pediatrics/Cardiology
Young Patient With Concurrent Congenital Heart Defects Undergoes Transplant

Case details, patient outcomes and lessons learned

Ad